Dr. Corey Cutler, MD, MPH, FRCPC, Medical Director, Stem Cell Transplant Program, Dana-Farber Cancer Institute and Vice President, American Society for Transplantation and Cellular Therapy (ASTCT) and GVHD patient Meredith A. Cowden, MA, AT, LPCC-S, Patient Advocacy Director of the Meredith A. Cowden Foundation discuss graft-versus-host-disease (GVHD), a rare disease that commonly impacts allogeneic (meaning cells that come from a donor) blood and marrow transplant recipients, the inaugural GVHD Day on Feb 17, 2023, the importance of bringing attention to this rare disease, and a new website for the GVHD community to access a variety of educational resources and support tools. For more information visit GVHDAlliance.org.
Dr. Cutler received his MD from McGill University, Montreal, Canada. He subsequently received his MPH from the Harvard School of Public Health. He completed postgraduate training in Internal Medicine at the Royal Victoria Hospital, Montreal, followed by a fellowship in Hematology/Oncology at DFCI. In 2002, he joined DFCI, where he is currently the Medical Director of the Adult Stem Cell Transplantation Program.